Among all NSCLC cases, the CD40 rs1883832 CT heterozygotes had poorer OS compared to TT and CC homozygotes after 2, 3, and 5 years of observation on univariate analysis (p=0.015, p=0.005, and p=0.017, respectively, Figure 1). The gene discussed is CD40; the disease is non-small cell lung carcinoma.